Broadridge Financial Solutions
BR · NYSE
About BR
- Employees
- 15,000
- Headquarters
- Lake Success, New York
- Listed
- Mar 22, 2007
- Sector
- Industrials
- Industry
- Professional Services
- Website
- broadridge.com
BR key statistics
- Market cap
- 19.77B
- Price-earnings ratio
- 18.24
- Dividend yield
- 2.26%
- Average volume
- 806.27K
- Volume
- 874.33K
- Open price
- $177.40
- High today
- $180.60
- Low today
- $177.40
- 52 Week high
- $236.02
- 52 Week low
- $133.83
Broadridge Financial Solutions (BR) at a glance
As of Oct 20, 2026, Broadridge Financial Solutions (BR) shares are priced at $179.99, giving the company a market cap of 19.77B, a price-to-earnings ratio of 18.24 and a dividend yield of 2.26%.
Today the stock has traded between $177.40 and $180.60. The current price is 1.5% above the day's low and 0.3% below its high.
Volume so far is 874.33K shares, in line with the average of 806.27K shares a day.
Over the past year Broadridge Financial Solutions has ranged from $133.83 to $236.02, and now sits 45% of the way up that range.
Broadridge Financial Solutions met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $3.82 per share against an estimate of $3.87.
The average analyst price target is $221.79, 23.2% above the current price, from 6 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy50.0%
- Hold50.0%
- Sell0.0%
- Low
- $177.76
- Now
- $179.99
- High
- $268.90
BR earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 3 of the last 8 quarters, by 1.4% on average.
- Q3 FY24: reported $2.23 per share against an estimate of $2.30
- Q4 FY24: reported $3.50 per share against an estimate of $3.59
- Q1 FY25: reported $1.00 per share against an estimate of $0.9991
- Q2 FY25: reported $1.56 per share against an estimate of $1.52
- Q3 FY25: reported $2.44 per share against an estimate of $2.50
- Q4 FY25: reported $3.55 per share against an estimate of $3.60
- Q1 FY26: reported $2.72 per share against an estimate of $2.68
- Q2 FY26: reported $3.82 per share against an estimate of $3.87
BR news
- Press releasePRNewswire
- Press releasePRNewswire
Broadridge's Distributed Ledger Repo Processes $7.5 Trillion in September
- Press releasePRNewswire
Broadridge Nominates Srinivas Tallapragada to its Board of Directors
- Press releasePRNewswire
Broadridge and Korea Securities Depository Sign MOU to Support Modernization of Proxy Voting for International Investors Holding Korean Equities
- Surbhi Jain
EXCLUSIVE: AI Has A Blind Spot, Here Are 3 Overlooked Stocks
- Press releasePRNewswire
Boaz Lahovitsky Joins Broadridge as President of Wealth Management
- Press releasePRNewswire
U.S. Treasury Central Clearing Survey: Broad Industry Readiness for Cash Clearing, Industry Moving Towards Execution but Work Remains Ahead of Repo Deadline
- Press releaseBusiness Wire
Zelis® Names Jim Young Chief Financial & Administrative Officer, Succeeding Retiring Brian Gladden
Similar companies
Companies in the same industry as Broadridge Financial Solutions
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
- WFFWF Holding$0.0929−3.83%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.